The abstract is read at the publisher; the summary is JClub's.
Epigenetic clock estimates place biological onset of Barrett’s esophagus at a median age of 29.5 years (IQR 22.5–45.8) in a Northern Ireland cohort, decades before diagnosis.
- Why it matters: Screening starts at age 50 with risk factors, but the timing of biological BE onset and how long lesions persist before clinical detection are unclear, limiting risk-focused screening.
- What they did: The study applied a BE epigenetic clock to 61 samples from 41 patients in Northern Ireland and 164 samples from 140 patients in an independent UK cohort, comparing dwell time with matched non-dysplastic controls and using pre-progression biopsies in a longitudinal set.
- The result: Dwell time was longer with concurrent dysplasia (median difference 14.3 years; p=0.0042) or EAC (12.5 years; p=0.0002), and dwell time over 19.8 years predicted higher odds of HGD/EAC progression (OR=12.1, 95% CI 3.7–47.5; p=9.96 x 10-9).
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.